CryoCell International (CCEL)
(Delayed Data from AMEX)
$6.20 USD
-0.29 (-4.47%)
Updated Aug 30, 2024 11:35 AM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
CCEL 6.20 -0.29(-4.47%)
Will CCEL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CCEL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for CCEL
Maxim Group Gives a Buy Rating to Cryo-Cell International (CCEL)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results
CRYO-CELL International, Inc. trading resumes
CRYO-CELL International, Inc. trading halted, volatility trading pause